期刊文献+

阿法替尼合成工艺研究

Synthesis of Afatimib
下载PDF
导出
摘要 目的对阿法替尼的合成工艺进行研究。方法以6-氨基-7-羟基-3,4-二氢喹唑啉-4-酮和乙酰氯分别作为起始原料,经过乙酰化反应、氯代反应、水解反应、Mitsunobu反应、酰化反应,缩合得到最终目标产物。结果试验总收率为46.6%。结论该制备方法原料易得,工艺简洁,经济环保,有利于该药品的工业化生产。 Objective To study the synthetic technology of afatimib.Methods 6-amino-7-hydroxy,4-dihydro-quinazolin-4-one and acetyl chloride were used as the starting materials,and the target compound was obtained after a series of chemical reactions including acetylation reaction,chlorination reaction,hydrolysisreaction,Mitsunobu reaction,and acetylation reaction.Results The overall yield was 46.6%.Conclusion This improved process could lower the cost of preparation,simplify the operating conditions,increase the yield,and is more suitable for industrial purposes.
出处 《解放军药学学报》 CAS CSCD 2017年第5期422-424,444,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 MITSUNOBU反应 缩合反应 合成 afatimib Mitsunobu reaction condensation reaction synthesis
  • 相关文献

参考文献2

二级参考文献45

  • 1朱翊,傅得兴.T细胞选择性核苷类似物奈拉滨[J].中国新药杂志,2007,16(3):252-255. 被引量:6
  • 2Jemal A,Murray T,Samuels A. Cancer statistics[J].CA:A Cancer Journal for Clinicians,2003,(01):5-26.doi:10.3322/canjclin.53.1.5.
  • 3Rowinsky EK. The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anti-cancer agents[J].Drugs,2000,(01):1-14,41-42.doi:10.1517/14728220903540265.
  • 4Sibilia M,Kroismayr R,Lichtenberger BM. The epidermal growth factor receptor:from development to tumorigenesis[J].Differentiation,2007,(09):770-787.doi:10.1111/j.1432-0436.2007.00238.x.
  • 5Hirsch FR,Varella-Garcia M,Cappuzzo F. Predictive value of EGFR and HER2 over -expression in advanced non-small-cell lung cancer[J].Oncogene,2009,(Suppl1):S32-S37.
  • 6Kancha RK,von Bubnoff N,Peschel C. Functional analysis of epidermal growth factor receptor(EGFR)mutation and potential implications for EGFR targeted therapy[J].Clinical Cancer Research,2009,(2):460-467.doi:10.1158/1078-0432.CCR-08-1757.
  • 7Gazdar AF. Activating and resistance mutations of EGFR in non-small cell lung cancer:role in clinical response to EGFR tyrosine kinase inhibitors[J].Oncogene,2009,(suppl1):S24-S31.doi:10.1038/onc.2009.198.
  • 8Sibilia M,Kroismayr R,Lichtenberger BM. The epidermal growth factor receptor:from development to tumorigenesis[J].Differentiation,2007,(09):770-787.doi:10.1111/j.1432-0436.2007.00238.x.
  • 9Riely GJ,Pao W,Pham D. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib[J].Clinical Cancer Research,2006,(3 Pt 1):839-844.
  • 10Leidner RS,Fu P,Clifford B. Genetic abnormalities of the EGFR pathway in African American patients with non-small-cell lung cancer[J].Journal of Clinical Oncology,2009,(33):5620-5626.doi:10.1200/JCO.2009.23.1431.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部